公司资料
Pacific Biosciences 股价、新闻与催化剂
- 股票代码:
- PACB
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.21 USD (+5.22%)
收盘价
最后更新: 2026年8月17日
491M USD
市值
股价为何变动
As of Aug 17, 2026, PACB closed up 5.22% at $1.21. No new same-company headline was identified in the current news window.
公司概览
Long-Read Sequencing
Pacific Biosciences, or PacBio, develops high-accuracy long-read sequencing systems used in research and clinical genomics. Its HiFi technology reads long DNA fragments while maintaining high base-level accuracy.
Sequencing Platforms
The company's instrument portfolio includes high-throughput Revio systems and benchtop Vega systems. Revenue combines instrument placements with recurring consumables, service and software. PacBio technology is used for whole-genome sequencing, rare-disease analysis, population genomics, microbial research and other applications where resolving structural variation and complex genomic regions is important.
未来催化剂
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。